Duodart dutasteride/tamsulosin regulatory update

GlaxoSmithKline said Duodart 500 µg dutasteride/400 µg tamsulosin was approved in Europe under the decentralized procedure to treat moderate to severe symptoms of benign prostatic hyperplasia (BPH) an...